Veregen
These highlights do not include all the information needed to use VEREGEN safely and effectively. See full prescribing information for VEREGEN. Veregen (sinecatechins) ointment, for topical use Initial U.S. Approval: 2006
Approved
Approval ID
2c1cd745-79ab-487d-b759-995794cedb92
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Aug 12, 2021
Manufacturers
FDA
PharmaDerm a division of Fougera Pharmaceuticals Inc.
DUNS: 043838424
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
sinecatechins
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code10337-450
Application NumberNDA021902
Product Classification
M
Marketing Category
C73594
G
Generic Name
sinecatechins
Product Specifications
Route of AdministrationTOPICAL
Effective DateAugust 12, 2021
FDA Product Classification
INGREDIENTS (1)
SINECATECHINSActive
Quantity: 150 mg in 1 g
Code: T432289GYZ
Classification: ACTIB